Viewing Study NCT03034304


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-03-05 @ 3:50 AM
Study NCT ID: NCT03034304
Status: TERMINATED
Last Update Posted: 2025-07-24
First Post: 2016-12-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
Sponsor: HRYZ Biotech Co.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MASCT-I,DC,T cell View
None Advanced solid tumors View